| Literature DB >> 33946831 |
Rukshana Ahmed1, Riaan Mulder1.
Abstract
Aerosol generation and a wide range of pathogens originating from the oral cavity of the patient contaminate various surfaces of the dental clinic. The aim was to determine the efficacy of vaporized hydrogen peroxide fogging on pathogens related to the dental environment and its possible application in dentistry. PICOS statement (Population, Intervention, Comparison/Control, Outcome and Study design statement) was used in the review. Six electronic databases were searched for articles published from 2010 to 2020. Articles written in English reporting vaporized hydrogen peroxide on pathogens deemed to be relevant to the dental environment were assessed. The quality of the studies was assessed using the risk-of-bias assessment tool designed for the investigation of vaporized hydrogen peroxide application in dentistry. A total of 17 studies were included in the qualitative synthesis. The most commonly reported single bacterial pathogen was Methicillin-resistant Staphylococcus aureus in five studies, and the viruses Feline calicivirus, Human norovirus, and Murine norovirus were featured in three studies. The results of the studies reporting the log kill were sufficient for all authors to conclude that vaporized hydrogen peroxide generation was effective for the assessed pathogens. The studies that assessed aerosolized hydrogen peroxide found a greater log kill with the use of vaporized hydrogen peroxide generators. The overarching conclusion was that hydrogen peroxide delivered as vaporized hydrogen peroxide was an effective method to achieve large levels of log kill on the assessed pathogens. The hydrogen peroxide vapor generators can play a role in dental bio-decontamination. The parameters must be standardized and the efficacy assessed to perform bio-decontamination for the whole clinic. For vaporized hydrogen peroxide generators to be included in the dental bio-decontamination regimen, certain criteria should be met. These include the standardization and efficacy assessment of the vaporized hydrogen peroxide generators in dental clinics.Entities:
Keywords: bio-decontamination; enumeration; hydrogen peroxide; stainless steel; vaporized hydrogen peroxide
Year: 2021 PMID: 33946831 PMCID: PMC8124733 DOI: 10.3390/ijerph18094748
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Search terms for database searches.
| Database | Search Terms |
|---|---|
| DOAJ | Hydrogen peroxide vapor OR Hydrogen peroxide vapor OR vaporized hydrogen peroxide (VHP), producing system OR Hydrogen peroxide fogger OR hydrogen peroxide in vitro AND ( decontamination or disinfection ) |
| Ebscohost | Hydrogen peroxide vapor OR Hydrogen peroxide vapour OR VHP producing system OR Hydrogen peroxide fogger OR hydrogen peroxide in vitro AND (decontamination or disinfection ) |
| Pubmed | (((((Hydrogen peroxide vapor) OR (Hydrogen peroxide vapour)) OR (HPV producing system)) OR (Hydrogen peroxide fogger)) OR (Hydrogen peroxide fog)) AND (decontamination) |
| Scopus | (((((Hydrogen peroxide vapor) OR (Hydrogen peroxide vapour)) OR (HPV producing system)) OR (Hydrogen peroxide fogger)) OR (Hydrogen peroxide fog)) AND (decontamination) |
| Sceilio | (((((Hydrogen peroxide vapor) OR (Hydrogen peroxide vapour)) OR (HPV producing system)) OR (Hydrogen peroxide fogger)) OR (Hydrogen peroxide fog)) AND (decontamination) |
| Web of Science | (Hydrogen peroxide vapo?r* OR HPV producing system* AND Enterococcus faecalis AND Candida albicans AND decontamination) |
Figure 1PRISMA flow diagram of the study selection.
The characteristics of the included studies for VHP decontamination (n = 17).
| Characteristics | |
|---|---|
| Publication Year | |
| 2010 | 1 (0.05) |
| 2011 | 3 (0.17) |
| 2012 | 3 (0.17) |
| 2014 | 1 (0.05) |
| 2015 | 1 (0.05) |
| 2016 | 2 (0.11) |
| 2017 | 3 (0.17) |
| 2019 | 2 (0.11) |
| 2020 | 1 (0.05) |
| Location | |
| United Kingdom | 8 (0.47) |
| Sweden | 3 (0.17) |
| USA | 2 (0.11) |
| Brazil | 1 (0.05) |
| France | 1 (0.05) |
| Germany | 1 (0.05) |
| The Netherlands | 1 (0.05) |
| Hydrogen Peroxide Vapourizing machine | ( |
| Aeroclave | 1 (0.05) |
| Bioquell | 1 (0.05) |
| Bioquell BQ-50 | 1 (0.05) |
| Bioquell Clarus C | 2 (0.10) |
| Bioquell Clarus L | 1 (0.05) |
| Bioquell Clarus R | 3 (0.15) |
| Bioquell Clarus S | 1 (0.05) |
| Bioquell Q10 | 4 (0.21) |
| Liquid Verne Veiling equipment | 1 (0.05) |
| Sterinis aHP | 1 (0.05) |
| Steris La Calhene VHP | 1 (0.05) |
| Steris VHP | 1 (0.05) |
| Sterinis system SR2 | 1 (0.05) |
| Assessed Pathogen: | |
| Candida | ( |
| Various | 34 (100) |
| Bacteria | ( |
|
| 1 (0.03) |
|
| 1 (0.03) |
|
| 1 (0.03) |
|
| 1 (0.03) |
|
| 1 (0.03) |
|
| 1 (0.03) |
|
| 1 (0.03) |
| 9 (0.33) | |
| MDR | 1 (0.03) |
| Methicillin-resistant | 5 (0.18) |
|
| 1 (0.03) |
|
| 1 (0.03) |
|
| 1 (0.03) |
| 1 (0.03) | |
|
| 1 (0.03) |
| Virus | |
|
| 2 (0.09) |
| 1 (0.04) | |
|
| 1 (0.04) |
|
| 3 (0.14) |
| 1 (0.04) | |
|
| 1 (0.04) |
|
| 3 (0.14) |
| 1 (0.04) | |
| 3 (0.14) | |
|
| 1 (0.04) |
|
| 1 (0.04) |
|
| 1 (0.04) |
| 1 (0.04) | |
| Transmissible | 1 (0.04) |
| Characteristics: | |
| Method of inoculation | |
| Sabouraud’s dextrose agar and fabric | 2 (0.06) |
| Stainless steel 10 mm-diameter discs/coupon | 5 (0.17) |
| Stainless steel 3 mm-diameter discs/coupon | 1 (0.03) |
| Stainless steel 2.2 cm × 2.5 cm disc | 1 (0.03) |
| Tyvek-pouched stainless steel disc/coupon | 5 (0.17) |
| Plastic plates | 2 (0.06) |
| Steel embossing tape 2.5 cm × 5 cm | 1 (0.03) |
| Roller bottle | 1 (0.03) |
| Unspecified stainless steel/coupon | 4 (0.14) |
| Gauze | 1 (0.03) |
| Glass | 1 (0.03) |
| Painted joint tape | 1 (0.03) |
| Wood | 2 (0.06) |
| Ceramic tile | 1 (0.03) |
| N95 Filter medium | 1 (0.03) |
| Efficacy: Log kill | |
| >8 log | 1 |
| >6 log | 4 |
| >4 log | 4 |
| >3 log | 2 |
| <2 log | 2 |
| 1.3–3.5 log reduction | 1 |
| Log reduction not specified | 4 |
Figure 2Risk of bias summary.
Summary of items regarded in the risk assessment of the chosen article.
| Author | Country of Study | Aim/Objective | Pathogen Used | Methodology:-Hydrogen Peroxide Concentration | Blinding and Controls | Sample Hanling and Contamination Prevention | Failed Experiments and Data/Results Not Presented | Pathogens Placed on Material | Outcome (Level of Bio-Decontamination) |
|---|---|---|---|---|---|---|---|---|---|
| A Abdolrasouli et al. 2017 | United Kingdom | In vitro evaluation of the efficacy of VHP on standard and outbreak | 34 different yeast isolates: 4 strains ( | Bioquell machine, No H2O2 liquid concentration, performed following manufacture instructions. 8 g of H2O2/m3. | No blinding. One | Did not state how long after fogging well plates were closed to prevent contamination. | One Indian | Well plates. | Data provided evidence |
| E Berrie et al. 2011 | United Kingdom | In vitro efficacy of inactivation of recombinant adenovirus by VHP. | Dried recombinant | Bioquell Clarus S machine, 60 mL of 30% H2O2 liquid concentration, performed dwell time 45 min. Whole VHP cycle 3 h | Exposed and non-exposed samples to VHP. BI (Biological Indicator) indicators used. The experiment is one disc per dilution and repeated in triplicate | Immediately after the experiment, the samples were transferred to a sterile microbiological safety cabinet. | One to two logs of pathogen lost due to drying or recovery method compared to wet reference samples compared to experiment two at the titer. Viability reduction data explained in the article. | Stainless steel 10-mm-diameter discs. | Data provided evidence |
| M Eterpi et al. 2010 | France & United Kingdom | In vitro evaluation of the efficacy | VHP100 Steris machine. 30% H2O2 liquid concentration. Three cycles 1200 ppm/15 min; 400–500 ppm/60 min; 180–200 ppm/4 h. | No blinding. VHP unexposed samples kept under a laminar flow hood in sealed Petri dishes for the same time cycle and managed the same as exposed coupons. No BI used. Six treated samples with each method and repeated for times. | Samples were transferred to an SP4-glucose broth immediately after VHP exposure. | Less than one log of pathogen lost due to drying or recovery method as described by Nagatomo et al. 2001 with loss due to recovery ≤0.5 log. Neutralization an additional ≤0.5 log. Viability reduction data explained in the article. | Stainless steel coupons of 1 cm × 3 cm. | Data provided evidence | |
| T. Y. Fu et al. 2011 | United Kingdom | Compare the efficacy, efficiency of VHP and aHP. | Methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and Acinetobacter baumannii. | Bioquell Clarus R machine. 30% H2O2 liquid. SR2 Sterinis machine with a 5% H2O2 liquid and silver ion (50 ppm) and orthophosphoric acid (<50 ppm), dose 6 mL/m3 recommended by the manufacturer. | No blinding. Both exposed and non-exposed to VHP. BI used. Four cycles per machine with each cycle consisting of three unexposed VHP/aHP and three dry VHP/aHP discs for water, 3% BSA (Bovine Serum Albumin) and 10% BSA. The control was cycled separately over four cycles. | Did not state how long after fogging discs were transferred to prevent contamination, nor the overnight drying to prevent contamination. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | Stainless steel discs with a diameter of 10 mm. | The VHP system achieved a greater level of biological inactivation between 4–6 log for most locations than the aHP system 1–5 log depending on the pathogen. |
| Goyal et al. 2014 | United Kingdom | Evaluate the in vitro efficacy of three volumes of VHP on selected viruses with surface contamination. | FCV as a | Bioquell Clarus L machine. 35% H2O2 liquid. Hydrogen peroxide at 2 mL/min for 1, 2, 5 min followed by 1.5 mL/min or 15 min equating to the following different volumes: 25, 27, and 33 mL with the treatment time between 2–3 h for the completed cycle. | No blinding. Non-VHP exposed inoculated discs at room temperature. Four BI were exposed to the VHP in corners of the environmental chamber. Positive BI control was not exposed to VHP. 8% Fetal Bovine Serum (FBS) served as soiling present in the culture medium. Each experiment had inoculated discs exposed to each vaporized volume of VHP and one disc not exposed to VHP. | Discs are left to dry in a biosafety cabinet to prevent contamination. After VHP the discs including the non-exposed control discs were transferred immediately to the environmental chamber for titration. | Data was determined concerning the control disc. This allows direct comparison to the test and control discs having the same log loss, making the comparison more accurate. But also leads to not knowing what the log loss of viral load is. Loss of virus log particles during the methodology of drying and recovery. Not calculated | 10 mm stainless steel discs. | VHP was virucidal for viruses assessed dried on surfaces, suggesting that VHP can be considered for the disinfection of virus-contaminated surfaces based on the 8% FBS surface contamination. |
| Holmdahl et al. 2011 | Sweden | Comparison of VHP and aHP to BI in various locations. | BI with | Steris VHP machine. 5% H2O2 liquid. 6 mL/m3 with 100–150 ppm. Bioquell Q10 machine. 35% H2O2 liquid. 900 mL per test and results in 6.6 g/m3. 338 ppm peak, 3 h. | No blinding. BI was used as control. | BI in Tyvek pouches | Direct comparison of two machines on BI. All results presented. | BI stainless steel disc placed in various locations in the room. | All results presented for the same areas assessed for the two machines. VHP showed a 100% negative result while aHP presented with multiple positive results, the inconsistency with the aHP was 10% kill (100 ppm) followed by two cycles of 79% kill, with the ppm in cycles 2 and 3 being 130 and >150 ppm respectively. |
| Holmdahl et al. 2016 | Sweden | Evaluate the efficacy of VHP in six locations for two virus pathogens with surface contamination. | FCV, feline permissive cell line (FCWF). MNV and permissive murine cell line (RAW 264.7) | Bioquell Q10 machine. As per the manufacturer. No H2O2 liquid concentration. Gassing time 40–50 min, dwell time 15 min. VHP ppm range 474–505 ppm with a total cycle time of 3 h. | Virus prepared in triplicate in well plates. Two inoculated plates and BI not VHP exposed two areas of the control room. BI exposed at all the positions with VHP next to virus inoculated plates. Each VHP exposure experiment was repeated in triplicate. | Well plates left to dry at room temperature under a hood for 2 h and stored. | Loss of virus log particles during the methodology of drying and recovery were calculated. | Well plates | VHP was virucidal for viruses assessed dried on surfaces, suggesting that VHP can be considered for the disinfection of virus-contaminated surfaces based on the 10% FBS surface contamination. |
| Holmdahl et al. 2019 | Sweden | Assess | Two | Bioquell Q10 machine. No H2O2 liquid concentration. 860 ppm VHP for 33 min gassing and 55 min dwell. This resulted in 205 g of H2O2 used. | No blinding. BI and mock samples with no VHP exposure. | Virus samples dried in 35 mm diameter wells of six-well plates mock and VHP treated samples. | Data was determined concerning the lowest detection limit of 10−0.5. This allows direct comparison to the test and control discs having the same log loss, making the comparison more accurate. But also leads to not knowing what the log loss of viral load is. | Well pates | BI deactivated and |
| Lemmen et al. 2015 | Germany | Efficacy of VHP on five pathogens dried onto various hard surfaces. | MDR MRSA and MDR VRE, MDR | Bioquell Q10 machine. | No blinding. BI used. Four of each material inoculated with the pathogen and distributed in four locations exposed to VHP and the same number not exposed to VHP as controls. BI placed in 4 corners of the room and 3 challenge locations. | Kept on a sterile basis until experiment and after VHP exposure transferred to a sterile glass tube with 1 mL distilled water. | Lost pathogens are known and presented in the article and mean log reduction is calculated. | Stainless steel discs, gauze | VHP inactivated all spore BI (>6 log10 reduction), and no MRSA, VRE, or MDR |
| Montazeri et al. 2017 | USA | Inactivation of | FCV. Outbreak | AeroClave System 3110. 7.5% H2O2 liquid. No air handling unit during vapor process, at end of cycle turned on for 20 min. 7.1–15.9 mL/m3 was achieved, with 5 min dwell time following the manufacturer’s recommendation. Then the air handling unit was switched on for 20 min. | No blinding. No BI used. 7 locations in BSL-3 laboratory assessed with VHP. Inoculated coupons not exposed to VHP were outside the laboratory for the duration of the experiment. | Air-dried in a biosafety hood. And used immediately for the experiment. After the experiment, the samples were transferred to PBS tubes. | Data was determined to the control disc. This allows direct comparison to the test and control discs having the same log loss, making the comparison more accurate. But also leads to not knowing what the log loss of viral load is. | Stainless steel embossing tape | No trend was observed for |
| Murdoch et al. 2016 | United Kingdom | Assess the application of three different liquid concentrations for VHP. | MRSA and | Bioquell BQ50 machine. 5, 10, and 35% H2O2. 640 g hydrogen peroxide over 40 min and 200 min dwell time. | No blinding labeled containers. BI used. Positive and negative controls. Every 10 min throughout the experiment a BI was exposed for 10 min. | All specimens were placed in labeled 30 mL containers. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | Stainless steel discs | 35% hydrogen peroxide is ideal. |
| Otter et al. 2012 | United Kingdom | Efficacy of VHP against methicillin-resistant Staphylococcus aureus on various surfaces. | MRSA | Bioquell Clarus R machine. No H2O2 liquid concentration. VHP mean concentration | No blinding. No BI used. Control discs were not VHP exposed. The experiment ran in triplicate per period for each contaminant material. | Air-dried in the test room air, then VHP exposure and immediately enumerated. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | Stainless steel discs | Relative susceptibility to VHP was 10% BSA < TSB < 3% BSA = water. At a ppm achieved and >75 min exposure, no MRSA was recovered on the discs. |
| Petit et al. 2017 | Brazil | Efficacy of VHP against | Three serotypes of | Bioquell Clarus R machine. 35% H2O2 liquid. 115 min. VHP injection time 75 min, 40 min dwell time. | No blinding. No validated BI manufactured by VHP producers. Positive controls of three serotypes. Three replicate cycles of 15 BI produced from FMDV for VHP exposure. Five samples for each viral serotype were produced. One plosive control per serotype for the duration of the experiment was stored in a refrigerator. | Dried in class 2 biological safety cabinet. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | Inside the cap of the polypropylene cryogenic tube. | Three |
| Pottage et al. 2012 | United Kingdom | Comparison of log kill of BI vs MRSA after VHP exposure. | A Steris VHP-1000ARD machine. 35% H2O2 liquid. 750 ppm maintained in chamber. | No blinding. Random removal of VHP exposed samples. 18 MRSA and 18 BI indicators placed in sterile Petri dishes and VHP exposed for pre-determined periods. Three unexposed stainless steel discs of each pathogen were used. | Inoculated stainless steel discs air-dried for 1 h. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | BI on stainless steel discs sealed in Tyvek packages. | BI greater log kill than MRSA for the same periods of exposure. | |
| Pottage et al. 2019 | United Kingdom | Efficacy of VHP on dried bacteria. | Bioquell Clarus C machine. 35% H2O2 liquid. 90 min cycle. | No blinding. Three controls tied in double plastic bags to determine the loss of log pathogen. 3 control samples were used as the start pathogen load. 12 produced BI for each VHP run to allow triplicate exposure. Three control BI from a VHP manufacturer used per VHP cycle. | Dried in a biological cabinet for 1 h. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | Stainless steel coupons in Petri dishes | This study demonstrates that VHP can inactivate a range | |
| Tuladhar et al. 2012 | The Netherlands | Virucidal efficacy of VHP against respiratory and | Boneco 7131 machine. 12% H2O2 liquid. 120–134 ppm at a flow rate of 2.3 L/h. | No validated BI manufactured by VHP producers. Triplicate samples per virus were performed twice. Control samples were not VHP exposed. | Dried in a biohazard cabinet. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | Stainless steel, framing panel, and gauze carriers. | VHP effective against pathogens assessed. | |
| Wood et al. 2020 | USA | Assess the decontamination efficacy of VHP on phages. | Bacteriophage viruses, MS2 and | Humidifier with 3 or 8% H2O2 liquid generated to 25 ppm. Bioquell Clarus C machine. 35% H2O2 liquid. 25 ppm and 400 ppm generated. | No validated BI manufactured by VHP producers. Inoculated samples, not VHP exposed, and inoculated samples VHP exposed. Two blank samples. Completed in triplicate. | Samples made and dried in a biosafety cabinet. After the experiment coupons were sealed and transferred to the biosafety cabinet. | No pathogens lost or contaminated samples were described or considered in the methodology. All data presented. | Stainless steel, glass, tile, N95 mask material, painted joint tape, wood. | Extrapolating from these results for both an enveloped and non-enveloped virus, we would expect LCHP would be a viable decontamination option for |